ArticleCureus2025
Toe Necrosis: A Surprising Herald of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic vasculitides can affect any type of blood vessel and can present with various signs and symptoms depending on the site and type of affected blood vessels. The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) can affect small- to medium-sized vessels. It can involve various organs and present with varying clinical and pathological features. Although rare, it can affect the blood vessels of the toes, leading to distal ischemia and gangrene. A 74-year-old woman with multiple comorbidities presented with symptoms of chronic nasal congestion, joint pain, and neuropathy, prompting autoimmune evaluation. Due to positive antinuclear antibody and perinuclear ANCA titer, initial treatment with low-dose prednisone and methotrexate was introduced. However, later during the course, she developed bilateral toe necrosis despite being on treatment. The workup for neurological and cardiovascular causes for the toe necrosis was negative. The patient ultimately required bilateral metatarsal amputation. Post-surgery, she was treated with rituximab and prednisone, which resulted in improvement in vasculitis. This case highlights the importance of recognizing rare presentations of AAV to enable timely intervention and prevent severe complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.